Ralph Grosswald
CIK: 0001826084
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dogwood Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 5, 2026DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
82.5K shares- - Dec 4, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
150K shares- - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
12.1K shares-
1-3 of 3 transactions
About Grosswald Ralph
Grosswald Ralph (SEC CIK 0001826084) files insider reports with the SEC as SVP OF OPERATIONS of Dogwood Therapeutics, Inc. (DWTX).
Signal8 holds 3 ownership filings by Grosswald Ralph, all Form 4s, filed between Jul 1, 2025 and Mar 6, 2026. Those filings report 3 transactions, from Jun 27, 2025 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Grosswald Ralph's filings is in ALPHARETTA, GA.
Recent filings by Grosswald Ralph
Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)
- Sealbond Ltd, Director
- De La Rosa Abel, Director
- Thomas John C, Director
- Whitley Richard James, Director
- Keefer David R, Director
- Walsh Angela, Chief Financial Officer